<DOC>
	<DOCNO>NCT00347373</DOCNO>
	<brief_summary>The purpose clinical trial examine effect low high dose conjugate linoleic acid supplement body composition obese human . Individuals body mass index 30 35kg/m2 randomize receive either placebo , 3.2gCLA , 6.4g CLA daily twelve week . Changes body composition , weight , clinical laboratory value compare three group .</brief_summary>
	<brief_title>Effect Conjugated Linoleic Acid Supplement Body Composition</brief_title>
	<detailed_description>Sixty healthy obese adult volunteer enrol randomize either : 1 ) placebo , 2 ) 3.2 g CLA , 3 ) 6.4 g CLA group supplement 12 week . Body fat mass ( BFM ) lean body mass determine DEXA baseline twelve week intervention . In addition , indirect calorimetry perform baseline twelve week measure change energy expenditure . The effect CLA supplementation weight , waist hip measurement , BMI also determine 12 week . Plasma CLA pill count measure indication compliance . Several blood parameter monitor throughout study , five random 24-hour recall survey use monitor dietary intake CLA-rich food , energy , micronutrient antioxidant .</detailed_description>
	<criteria>BMI 30 35 kg/m2 history chronic disease food allergy intolerances drug therapy diagnose disease lipidlowering use weightlowering medication diet use tobacco product current planned pregnancy use CLA supplement previous 3 month current substance abuse abnormal clinical laboratory value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>conjugate linoleic acid</keyword>
	<keyword>obesity</keyword>
	<keyword>body composition</keyword>
	<keyword>body fat mass</keyword>
	<keyword>lean body mass</keyword>
</DOC>